Skip to content

QuarterlyIQ Insights · ZBH

News & Events

Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.

Type
Direction
6 matches
  1. 2026-04-28Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 22, 2026, Suketu Upadhyay informed Zimmer Biomet Holdings, Inc. (the “Company”) of his intention to resign from the position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain of the Company, effective as of April 28, 2026, to pursue a new professional opportunity. Mr. Upadhyay’s departure is not…

    executive changecfo transitionneutralscore 81
  2. 2026-04-28Item 2.02

    Results of Operations and Financial Condition. On April 28, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report. The information contained in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed…

    earnings preannouncementearnings beatpositivescore 73
  3. 2026-02-10Item 2.02

    Results of Operations and Financial Condition. On February 10, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter and year ended December 31, 2025. A copy of the press release is attached as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report. The information contained in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deem…

    earnings preannouncementearnings inlineneutralscore 67
  4. 2026-01-12Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;Compensatory Arrangements of Certain Officers. On January 8, 2026, Mark Bezjak, a named executive officer in the 2025 proxy statement of Zimmer Biomet Holdings, Inc. (the “Company”), informed the Company that he will resign his employment, including all officer positions with the Company and its affiliates, effective as of January 16, 2026, to pursue another business opportunity. As previously r…

    executive changeofficer changeneutralscore 57
  5. 2025-09-04Item 8.01

    Other Events. On September 4, 2025, Zimmer Biomet Holdings, Inc. (the “ Company ”) issued two new series of senior unsecured debt securities denominated in Swiss francs, comprising CHF 210,000,000 aggregate principal amount of the Company’s 0.930% Bonds 2025 – 2030 (the “ Tranche A Bonds ”) and CHF 390,000,000 aggregate principal amount of the Company’s 1.560% Bonds 2025 – 2035 (the “ Tranche B Bonds ” and, together with the Tranche A Bonds, the “ Bonds ”). The Bonds were issued pursuant to a…

    capital allocationbuyback announcedpositivescore 52
  6. 2021-10-29Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 29, 2021, Zimmer Biomet Holdings, Inc. (the “Company”) announced that Carrie Nichol, the Vice President, Controller and Chief Accounting Officer, and the principal accounting officer, of the Company, will be departing from the Company effective November 26, 2021. Ms. Nichol is pursuing another employment opportunity and her departure is…

    executive changepao transitionneutralscore 57
Coming next

General-purpose headline news (a news API), full earnings call transcripts, and macro/sector items flagged when they directly affect this stock are not yet in the marts. Today this tab covers SEC filings surfaced via mart.stock_material_events_history.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.